In fact, dysregulation of PLCB4 signaling has been suggested to be linked to various brain disorders (Yang et al. 2016) which may indicate contribution of phospholipase C β 4 deficiency to neurodegeneration in MPS. The gene discussed is PLCB4; the disease is mucopolysaccharidosis.